Skip to main content
. 2023 Jan 19;20(3):1879. doi: 10.3390/ijerph20031879

Table 3.

Analysis of medications with complete information before and after the implementation EMMS.

Secondary Outcome Variable Total Sample
(n = 246), Median (IQR)
Pre-
EMMS
(n = 112), Median (IQR)
Post-EMMS
(n = 134), Median (IQR)
Statistical Significance *
Medications per patients on admission
Medications documented
5 (3–9) 4 (3–7) 6 (3–10) p = 0.008
Medications with name, dose, and frequency documented 4 (1–8) 3 (0–6) 6 (2–10) p < 0.001
Medications per patients at discharge
Medications with name, dose, and frequency documented
7 (3–10) 6 (2–9) 7 (4–11) p = 0.049

* Mann–Whitney test.